ENTITY
InnoCare Pharma Ltd

InnoCare Pharma Ltd (9969 HK)

68
Analysis
Health CareChina
InnoCare Pharma Limited researches, develops, manufactures, and distributes pharmaceuticals. The Company produces antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products. InnoCare Pharma markets its products throughout China.
more
Refresh
11 Feb 2020 00:32

InnoCare Pharma IPO Initiation: Promising Prognosis

InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
383 Views
Share
02 Feb 2020 12:25

ECM Weekly (2 Feb 2020) - Smoore, Innocare, Kilcoy Global, Mr. DIY

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. ECM...

Share
28 Jan 2020 12:49

InnoCare (诺诚健华) Pre-IPO: Thoughts on Valuation

InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...

Logo
483 Views
Share
21 Oct 2019 10:13

InnoCare (诺诚健华) Pre-IPO: A Decent Team but Short of Clinical Stage Candidates

InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. We will discuss...

Logo
544 Views
Share
x